Wed, Apr 23, 9:15 PM (19 days ago)
**Intuitive Surgical, Inc. (ISRG) Q1 2025 Financial Summary** **Financial Health and Performance:** - **Revenue:** $2.25 billion, up 19% YoY. - **Net Income:** $703.7 million, up 29% YoY. - **EPS:** $1.95, up 27% YoY. - **Gross Margin:** 65%, down slightly from 66% YoY. - **Operating Margin:** 26%, up from 25% YoY. **Performance Metrics:** - **Procedures:** 732,000 da Vinci procedures, up 17% YoY; 30,700 Ion procedures, up 58% YoY. - **System Placements:** 367 da Vinci systems, up 17% YoY; 49 Ion systems, down 30% YoY. - **Installed Base:** 10,189 da Vinci systems, up 15% YoY; 853 Ion systems, up 41% YoY. **Trends and Uncertainties:** - **Tariffs:** Recent tariffs had an immaterial impact in Q1 but may increase costs in H2 2025. - **Supply Chain:** Continued supply chain challenges, but no material impact in Q1. - **Procedure Growth:** Strong growth in U.S. general surgery and OUS procedures. - **System Demand:** Increased demand for da Vinci 5 systems and leasing arrangements. **Future Operations Impact:** - **Capital Expenditures:** Expected to range from $650 million to $750 million in 2025. - **Cash Flow:** Strong cash flow from operations, with $9.10 billion in cash, cash equivalents, and investments as of March 31, 2025. - **Stock Repurchase:** No stock repurchases in Q1, with $1.1 billion remaining under the repurchase program. **Conclusion:** Intuitive Surgical demonstrated strong financial performance in Q1 2025, with significant revenue and earnings growth. The company continues to face uncertainties related to tariffs and supply chain challenges but remains well-positioned to capitalize on the growing demand for minimally invasive surgical procedures. The successful launch of the da Vinci 5 system and continued procedure growth are expected to drive future performance.